Pharmacia Corp. announced Wednesday that the FDA approved its application to expand the approved use of NasalCrom Nasal Spray for adults and children aged 6 and older to include children aged 2 and older. NasalCrom has been available to adults and children aged 6 and older since 1997. NasalCrom is a mast cell stabilizer that is meant to prevent allergic reactions before they begin. The medication prevents tiny cells in the nasal passage from breaking down and releasing its chemicals that cause the allergic reaction. N.J.-based drugmaker said in a statement.
Allergic rhinitis causes symptoms such as nasal stuffiness, runny or itchy nose, and sneezing.
It generally is triggered by reactions to pollen, mold, and dust mites. In children, it is the most common chronic disease. If left untreated, the disease can lead to other conditions, such as asthma, ear infections, sinusitis, sleep disorders, and a chronic cough. The most common form of prescription treatment is nasal steroid sprays. However, clinicians and parents are sometimes reluctant to use these medications because of the possible side effects.